These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19522915)

  • 1. The effectiveness of narrowband ultraviolet B on hypertrophic scar in a patient having an isomorphic phenomenon and vitiligo.
    Oiso N; Kawara S; Kawada A
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1003-4. PubMed ID: 19522915
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted broadband ultraviolet B phototherapy improves disorders characterized by increased dermal matrix.
    Do TT; Bailey EC; Wang F; Smith N; Lee W; Fisher GJ; Voorhees JJ; Kang S
    Br J Dermatol; 2009 Dec; 161(6):1405-7. PubMed ID: 19754865
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical placental extract: does it increase the efficacy of narrowband UVB therapy in vitiligo?
    Majid I
    Indian J Dermatol Venereol Leprol; 2010; 76(3):254-8. PubMed ID: 20445295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narrowband ultraviolet B phototherapy for inflammatory vitiligo with raised borders associated with Sjögren's syndrome.
    Tanioka M; Takahashi K; Miyachi YI
    Clin Exp Dermatol; 2009 Apr; 34(3):418-20. PubMed ID: 19120387
    [No Abstract]   [Full Text] [Related]  

  • 5. Home vs. outpatient narrowband ultraviolet B therapy for the treatment of nonsegmental vitiligo: a retrospective questionnaire study.
    Wind BS; Kroon MW; Beek JF; van der Veen JP; Nieuweboer-Krobotová L; Meesters AA; Bos JD; Wolkerstorfer A
    Br J Dermatol; 2010 May; 162(5):1142-4. PubMed ID: 20199553
    [No Abstract]   [Full Text] [Related]  

  • 6. Narrowband UVB therapy for vitiligo: does the repigmentation last?
    Sitek JC; Loeb M; Ronnevig JR
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):891-6. PubMed ID: 17658996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiotherapy for keloids and hypertrophic scars].
    Seegenschmiedt MH; Strittmatter HJ
    MMW Fortschr Med; 2008 Apr; 150(16):29-31. PubMed ID: 18557111
    [No Abstract]   [Full Text] [Related]  

  • 8. Keratoacanthoma in vitiligo lesion after UVB narrowband phototherapy.
    Brazzelli V; Barbagallo T; Prestinari F; Vassallo C; Agozzino M; Vailati F; Cespa M; Borroni G
    Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):211-3. PubMed ID: 16869872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimitotic drug injections and radiotherapy: a review of the effectiveness of treatment for hypertrophic scars and keloids.
    Wang XQ; Liu YK; Wang ZY; Wei Jun ; Jiang YZ; Qing Chun ; Lu SL
    Int J Low Extrem Wounds; 2008 Sep; 7(3):151-9. PubMed ID: 18757390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review.
    Nicolaidou E; Antoniou C; Stratigos A; Katsambas AD
    J Am Acad Dermatol; 2009 Mar; 60(3):470-7. PubMed ID: 19157641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative radiation protocol for keloids and hypertrophic scars: statistical analysis of 370 sites followed for over 18 months.
    Ogawa R; Miyashita T; Hyakusoku H; Akaishi S; Kuribayashi S; Tateno A
    Ann Plast Surg; 2007 Dec; 59(6):688-91. PubMed ID: 18046154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narrowband ultraviolet B phototherapy influences serum folate levels in patients with vitiligo.
    Murase JE; Koo JY; Berger TG
    J Am Acad Dermatol; 2010 Apr; 62(4):710-1. PubMed ID: 20227588
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo.
    Mehrabi D; Pandya AG
    Arch Dermatol; 2006 Jul; 142(7):927-9. PubMed ID: 16847214
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitiligo Potential Repigmentation Index: a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy.
    Benzekri L; Ezzedine K; Gauthier Y
    Br J Dermatol; 2013 May; 168(5):1143-6. PubMed ID: 23464539
    [No Abstract]   [Full Text] [Related]  

  • 15. Twenty-year follow-up using a postal survey of childhood vitiligo treated with narrowband ultraviolet B phototherapy.
    Lommerts JE; Njoo MD; de Rie MA; Wolkerstorfer A; Bekkenk MW
    Br J Dermatol; 2017 Sep; 177(3):e60-e61. PubMed ID: 28117877
    [No Abstract]   [Full Text] [Related]  

  • 16. Are very high cumulative doses of narrowband UVB safe in vitiligo?
    Momen S; Sarkany R
    Photodermatol Photoimmunol Photomed; 2017 Jul; 33(4):220-221. PubMed ID: 28370729
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudocatalase and narrowband ultraviolet B for vitiligo: clearing the picture.
    Gawkrodger DJ
    Br J Dermatol; 2009 Oct; 161(4):721-2. PubMed ID: 19780755
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of narrowband ultraviolet B versus excimer radiation in repigmenting vitiligo after minigrafting on the distal arms.
    Sheth VM; Currimbhoy SD; Feetham HJ; Graves MS; Chan J; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2012 Aug; 67(2):318-20. PubMed ID: 22794808
    [No Abstract]   [Full Text] [Related]  

  • 19. Ultraviolet A in vitiligo.
    El-Mofty M; Mostafa W; Youssef R; El-Fangary M; Elramly AZ; Mahgoub D; Fawzy M
    Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):214-6. PubMed ID: 16869873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultraviolet light exerts a major part of its therapeutic efficacy against vitiligo by production of prostaglandin E2.
    Namazi MR
    Dermatology; 2008; 217(2):149. PubMed ID: 18523390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.